U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
March 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ferguson Enterprises, Hartford Insurance Group and JP Morgan, on Monday.
HIGHLIGHTS
Ferguson Enterprises Inc FERG.N: Morgan Stanley raises target price to $280 from $270 |
Hartford Insurance Group Inc HIG.N: KBW cuts to market perform from outperform |
JP Morgan JPM.N: Piper Sandler cuts target price to $325 from $345 |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
3M Co MMM.N: Jefferies cuts target price to $160 from $180 |
4D Molecular Therapeutics FDMT.O: Jefferies assumes with buy rating; target $21 vs $40 |
Boston Scientific Corp BSX.N: Jefferies cuts target price to $110 from $120 |
BP BP.N: Gerdes Energy Research cuts to neutral from buy |
Carnival Corp CCL.N: JP Morgan cuts target price to $43 from $46 |
Chewy Inc CHWY.N: RBC raises target price to $47 from $43 |
Eyepoint Inc EYPT.O: Jefferies assumes coverage with buy rating; target price $33 |
Ferguson Enterprises Inc FERG.N: Morgan Stanley raises target price to $280 from $270 |
Fifth Third Bancorp FITB.O: Piper Sandler cuts target price to $54 from $57 |
Flutter Entertainment Plc FLUT.N: Morgan Stanley cuts target price to $190 from $315 |
Guardian Pharmacy Services GRDN.N: Jefferies initiates with buy rating; target $44 |
Hartford Insurance Group Inc HIG.N: KBW cuts to market perform from outperform |
Hartford Insurance Group Inc HIG.N: KBW cuts target price to $149 from $163 |
JP Morgan JPM.N: Piper Sandler cuts target price to $325 from $345 |
Karyopharm Therapeutics Inc KPTI.O: Piper Sandler cuts target price to $8 from $12 |
Kinder Morgan Inc KMI.N: RBC raises target price to $35 from $32 |
Legence Corp LGN.O: RBC raises target price to $64 from $48 |
Legend Biotech Corp LEGN.O: Piper Sandler cuts target price to $64 from $78 |
Monte Rosa Therapeutics Inc GLUE.O: Jefferies assumes with buy rating; PT $30 vs $31 |
PTC Therapeutics PTCT.O: Jefferies assumes with hold vs buy rating; target $76 vs $91 |
Regions Financial RF.N: Piper Sandler cuts target price to $28 from $31 |
Verastem Inc VSTM.O: Jefferies assumes coverage with buy rating; target $15 vs $19 |
Viridian Therapeutics VRDN.O: Jefferies assumes coverage with buy rating; target $45 |
Vor Biopharma Inc VOR.O: Jefferies initiates coverage with buy rating; target $50 |
